A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ALX Oncology Inc.
ALX Oncology Inc.
Massachusetts General Hospital
Seagen Inc.
Eli Lilly and Company
Boehringer Ingelheim
National Cancer Institute (NCI)
Montefiore Medical Center
Montefiore Medical Center
Astellas Pharma Inc
The New York Proton Center
USWM, LLC (dba US WorldMeds)
Pfizer
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Abramson Cancer Center at Penn Medicine
Pfizer
Varian, a Siemens Healthineers Company
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
University of Chicago
University of California, Irvine
ViroMissile, Inc.
University Health Network, Toronto
Duke University
AstraZeneca
Merus B.V.
Tizona Therapeutics, Inc
Dana-Farber Cancer Institute
University of California, San Diego
Betta Pharmaceuticals Co., Ltd.
IDEAYA Biosciences
University of Colorado, Denver
Boehringer Ingelheim
Daiichi Sankyo
SN BioScience
Perspective Therapeutics
Second Life Therapeutics
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
Novartis
UNICANCER
Inhibrx Biosciences, Inc
I-Mab Biopharma US Limited
VM Oncology, LLC
RenJi Hospital
Takeda
Gustave Roussy, Cancer Campus, Grand Paris
BicycleTx Limited